HER2 Support Group Forums
>
Search Forums
Search Results
User Name
Remember Me?
Password
Register
Gallery
FAQ
Members List
Calendar
Today's Posts
Search
Search Forums
Show Threads
Show Posts
Advanced Search
Search Gallery
Advanced Search
Go to Page...
Showing results 1 to 3 of 3
Search took
0.00
seconds.
Search:
Posts Made By:
phil
Forum:
Clinical Trials
08-28-2011, 09:32 AM
Replies:
7
TDM1 EAP -Good news for those in TDM1 EAP who need to travel
Views:
8,678
Posted By
phil
Re: TDM1 EAP -Good news for those in TDM1 EAP who need to travel
Want to make sure that all of you traveling to get t dm-1 know that the FDA has now allowed transfer to a site closer to your home. Our clinic in Va. has already begun the paperwork process....
Forum:
Clinical Trials
08-06-2011, 05:51 PM
Replies:
7
TDM1 EAP -Good news for those in TDM1 EAP who need to travel
Views:
8,678
Posted By
phil
Re: TDM1 EAP -Good news for those in TDM1 EAP who need to travel
Went to DC last wk. Got dose # 9. Latest Ct, counts look great. Still hearing that we will be able to transfer tx. to Boston in about a month. Access will close Sept. 6th. Have heard of at least ...
Forum:
Clinical Trials
06-21-2011, 07:38 PM
Replies:
7
TDM1 EAP -Good news for those in TDM1 EAP who need to travel
Views:
8,678
Posted By
phil
Re: TDM1 EAP -Good news for those in TDM1 EAP who need to travel
Genentech has asked the FDA to approve an " amendment to the Access protocol ". Allowing pts who are enrolled, and responding to the drug, to petition to switch the tx to a hospital/clinic closer to...
Showing results 1 to 3 of 3
Forum Jump
User Control Panel
Private Messages
Subscriptions
Who's Online
Search Forums
Forums Home
her2group
Herceptin / Tykerb
Caregivers Corner
Diet and Nutrition
Inflammatory Breast Cancer
Keeping Your Mind Off of BC
Profiles In Courage
My Healthcare Team
Clinical Trials
Articles of Interest
Events and Social Calendar
Breast Cancer Meeting Highlights
General Cancer News
Breast Cancer News
Breast Cancer Newsfeed
All times are GMT -7. The time now is
11:45 AM
.